Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis

Filková, Mária, Aradi, Borbala, Šenolt, Ladislav, Ospelt, Caroline, Vettori, Serena, Mann, Heřman, Filer, Andrew, Raza, Karim, Buckley, Christopher D, Snow, Martyn, Vencovský, Jiří, Pavelka, Karel, Michel, Beat A, Gay, Renate E, Gay, Steffen, Jüngel, Astrid·2014·Annals of the Rheumatic Diseases

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2012-202815

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 42

  1. Bukhari, 2001, Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study, Arthritis Rheum, 44, 1248, 10.1002/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8 · doi:10.1002/1529-0131(200106)44:6<1248::aid-art215>3.0.co;2-8
  2. Bukhari, 2003, Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study, Arthritis Rheum, 48, 46, 10.1002/art.10727 · DOI
  3. Raza, 2012, Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials, Ann Rheum Dis, 71, 1921, 10.1136/annrheumdis-2012-201893 · doi:10.1136/annrheumdis-2012-201893
  4. Nell, 2004, Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology (Oxford), 43, 906, 10.1093/rheumatology/keh199 · DOI · Paper page
  5. Möttönen, 2002, Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis, Arthritis Rheum, 46, 894, 10.1002/art.10135 · doi:10.1002/art.10135
  6. Emery, 2012, Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study, Ann Rheum Dis, 71, 989, 10.1136/annrheumdis-2011-201066 · DOI
  7. van der Linden, 2010, Long-term impact of delay in assessment of patients with early arthritis, Arthritis Rheum, 62, 3537, 10.1002/art.27692 · DOI · Paper page
  8. Aletaha, 2010, 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 · DOI · Paper page
  9. Allaart, 2011, Treatment strategies in recent onset rheumatoid arthritis, Curr Opin Rheumatol, 23, 241, 10.1097/BOR.0b013e3283454111 · doi:10.1097/bor.0b013e3283454111
  10. Mjaavatten, 2010, The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis, Arthritis Res Ther, 12, R76, 10.1186/ar2995 · doi:10.1186/ar2995
  11. Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
  12. Furer, 2010, The role of microRNA in rheumatoid arthritis and other autoimmune diseases, Clin Immunol, 136, 1, 10.1016/j.clim.2010.02.005 · DOI
  13. Filková, 2012, MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy, BioDrugs, 26, 131, 10.2165/11631480-000000000-00000 · DOI
  14. Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI · Paper page
  15. Stanczyk, 2011, Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation, Arthritis Rheum, 63, 373, 10.1002/art.30115 · DOI · Paper page
  16. Kawano, 2011, miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis, Ann Rheum Dis, 70, i88, 10.1136/ard.2010.138669 · DOI
  17. Kurowska-Stolarska, 2011, MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis, Proc Natl Acad Sci USA, 108, 11193, 10.1073/pnas.1019536108 · DOI · Paper page
  18. Niimoto, 2010, MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet Disord, 11, 209, 10.1186/1471-2474-11-209 · DOI
  19. Pauley, 2008, Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients, Arthritis Res Ther, 10, R101, 10.1186/ar2493 · DOI · Paper page
  20. Li, 2010, Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis, Arthritis Res Ther, 12, R81, 10.1186/ar3006 · DOI · Paper page
  21. Fulci, 2010, miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis, Hum Immunol, 71, 206, 10.1016/j.humimm.2009.11.008 · DOI · Paper page
  22. Weber, 2010, The microRNA spectrum in 12 body fluids, Clin Chem, 56, 1733, 10.1373/clinchem.2010.147405 · DOI · Paper page
  23. Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105 · DOI · Paper page
  24. Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282 · DOI · Paper page
  25. Murata, 2010, Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res Ther, 12, R86, 10.1186/ar3013 · DOI · Paper page
  26. Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 · DOI · Paper page
  27. van der Heijde, 2012, Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: a post-hoc analysis of the RAPID 1 trial, J Rheumatol, 39, 1326, 10.3899/jrheum.111171 · DOI
  28. Curtis, 2013, Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: Results from the TEAR Trial, J Rheumatol, 40, 527, 10.3899/jrheum.120715 · DOI
  29. Nakasa, 2008, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum, 58, 1284, 10.1002/art.23429 · DOI · Paper page
  30. Blüml, 2011, Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice, Arthritis Rheum, 63, 1281, 10.1002/art.30281 · DOI · Paper page
  31. Nakasa, 2011, The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis, Arthritis Rheum, 63, 1582, 10.1002/art.30321 · DOI · Paper page
  32. Li, 2012, Amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223, Arthritis Rheum, 64, 3240, 10.1002/art.34550 · DOI
  33. Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 13, 423, 10.1038/ncb2210 · DOI · Paper page
  34. Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc Natl Acad Sci USA, 108, 5003, 10.1073/pnas.1019055108 · DOI · Paper page
  35. Gilad, 2008, Serum microRNAs are promising novel biomarkers, PLoS One, 3, e3148, 10.1371/journal.pone.0003148 · DOI · Paper page
  36. Wang, 2010, Serum miR-146a and miR-223 as potential new biomarkers for sepsis, Biochem Biophys Res Commun, 394, 184, 10.1016/j.bbrc.2010.02.145 · DOI · Paper page
  37. Pigati, 2010, Selective release of microRNA species from normal and malignant mammary epithelial cells, PLoS One, 5, e13515, 10.1371/journal.pone.0013515 · DOI · Paper page
  38. Iguchi, 2010, Secretory microRNAs as a versatile communication tool, Commun Integr Biol, 3, 478, 10.4161/cib.3.5.12693 · DOI
  39. Sebastiani, 2011, Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients, Clin Exp Rheumatol, 29, 1058
  40. McInnes, 2007, Cytokines in the pathogenesis of rheumatoid arthritis, Nat Rev Immunol, 7, 429, 10.1038/nri2094 · DOI · Paper page
  41. Ospelt, 2008, The role of resident synovial cells in destructive arthritis, Best Pract Res Clin Rheumatol, 22, 239, 10.1016/j.berh.2008.01.004 · DOI
  42. Raza, 2005, Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Res Ther, 7, R784, 10.1186/ar1733 · DOI · Paper page

Cited by

See all 170

Metadata

Authors
Filková, M., Aradi, B., Šenolt, L., Ospelt, C., Vettori, S., Mann, H., Filer, A., Raza, K., Buckley, C. D., Snow, M., Vencovský, J., Pavelka, K., Michel, B. A., Gay, R. E., Gay, S., & Jüngel, A.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2014-10
Volume
73
Issue
10
Pages
1898-1904
ISSN
0003-4967
Cited by
170
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. https://app.cochat.ai/papers/10.1136/annrheumdis-2012-202815
The paper
Filková, M., Aradi, B., Šenolt, L., Ospelt, C., Vettori, S., Mann, H., Filer, A., Raza, K., Buckley, C. D., Snow, M., Vencovský, J., Pavelka, K., Michel, B. A., Gay, R. E., Gay, S., & Jüngel, A. (2014). Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-202815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.